Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • pharma news india

    Tag: pharma news india

    You Searched For "pharma news india"
    Indoco Remedies: USFDA retains OAI status for Goa plant

    Indoco Remedies: USFDA retains OAI status for Goa plant

    Farhat Nasim25 April 2019 9:50 AM IST
    Indoco Remedies' spokesperson said that the move is likely to withhold approval of pending abbreviated new drug applications (ANDAs) from Goa...
    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Eli Lilly to sell legacy antibiotics brands Ceclor, Vancocin, China facility to Eddingpharm

    Farhat Nasim23 April 2019 9:45 AM IST
    INDIANAPOLIS: Eli Lilly and Company today announced that it has entered into an agreement to sell the rights in China for two legacy Lilly antibiotic...
    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Patent Infringement: Cadila Healthcare, two others prohibited from launching Linagliptin Metformin Hydrochloride tablets

    Meghna A Singhania22 April 2019 2:07 PM IST
    AHMEDABAD: In a major setback, three Gujarat based pharmaceutical companies including Cadila Healthcare, West Coast Pharmaceutical Works Ltd and Maan...
    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Drugs registered on SUGAM portal to be exempted from obtaining licence for purpose of examination, test, analysis

    Meghna A Singhania21 April 2019 2:26 PM IST
    The exemption from obtaining a licence for Form 29 is subject to the condition that the information about the manufacturing of approved drugs for...
    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Ministry of AYUSH invites initial bids for strategic sale of IMPCL

    Garima18 April 2019 10:15 AM IST
    If the strategic sale of Indian Medicines Pharmaceutical Corporation Ltd (IMPCL), under the Ministry of AYUSH goes through the proceeds, would add to...
    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Adverse Reactions: Cefotaxime, Oflaxicin, Cefixime told to carry Warning by CDSCO

    Meghna A Singhania17 April 2019 12:26 PM IST
    New Delhi: The national regulatory body for Indian Pharmaceutical and Medical Device, Central Drugs Standard Control Organisation (CDSCO) has ordered...
    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Zydus Cadila announces phase III trials of Desidustat to treat non-dialysis anaemia

    Farhat Nasim17 April 2019 9:45 AM IST
    Zydus Cadila Group Chairman Pankaj R Patel said this innovation has the potential to bring about a paradigm shift in the management of CKD patients...
    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Cipla, Pulmatrix join hands to co-develop Pulmazole for treating asthma

    Garima16 April 2019 9:40 AM IST
    Pulmazole an inhaled iSPERSE formulation of the antifungal drug itraconazole for the treatment of allergic bronchopulmonary aspergillosis (ABPA) in...
    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Alembic Pharma receives USFDA nod for Bimatoprost Ophthalmic Solution

    Farhat Nasim15 April 2019 10:05 AM IST
    Bimatoprost Ophthalmic Solution, 0.03% is indicated for the reduction of elevated intraocular pressure in patients with open-angle glaucoma or ocular...
    Cipla launches respiratory inhalation therapy product Niveoli in India

    Cipla launches respiratory inhalation therapy product Niveoli in India

    Farhat Nasim12 April 2019 11:41 AM IST
    New Delhi: Drug major Cipla Friday announced the launch of its proprietary respiratory inhalation therapy product 'Niveoli' in India. Niveoli is used...
    Insider trading: Sun Pharma Senior Executive, wife pay over Rs 70 lakh settlement to SEBI

    Insider trading: Sun Pharma Senior Executive, wife pay over Rs 70 lakh settlement to SEBI

    Meghna A Singhania12 April 2019 10:59 AM IST
    Abhay Arvind Gandhi and his wife traded in Ranbaxy shares soon after Japanese major Daiichi, in 2014, agreed to sell Ranbaxy to Sun Pharma. New Delhi:...
    Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

    Intas Pharma launches Cancer Drug Eleftha for Rs 19,995; 65 percent lower than market rate

    Meghna A Singhania11 April 2019 10:50 AM IST
    Mumbai: In a move that will provide relief to cancer patients, drugmaker Intas Pharmaceuticals has recently announced the launch of Trastuzumab...
    PrevNext

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 13 Oct 2022 5:14 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier
    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

    © 2025 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    X
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok